Summary
Signal counts
Assets tracked: 3
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
BioNTech SE
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT06892548 | https://clinicaltrials.gov/study/NCT07111520 | https://clinicaltrials.gov/study/NCT07070232 | https://clinicaltrials.gov/study/NCT07186842
Assets